ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $11,684,000 | +15.9% | 67,888 | -15.5% | 0.22% | +18.1% |
Q2 2021 | $10,078,000 | -2.8% | 80,308 | +5.1% | 0.19% | -14.5% |
Q1 2021 | $10,364,000 | +38.5% | 76,424 | +30.7% | 0.22% | +31.0% |
Q4 2020 | $7,481,000 | -42.9% | 58,474 | -49.8% | 0.17% | -62.2% |
Q3 2020 | $13,109,000 | +2.8% | 116,496 | -13.0% | 0.44% | -3.5% |
Q2 2020 | $12,756,000 | -3.3% | 133,891 | -8.7% | 0.46% | -35.1% |
Q1 2020 | $13,186,000 | +17.7% | 146,721 | -30.6% | 0.71% | +37.6% |
Q4 2019 | $11,205,000 | +31.9% | 211,332 | -1.7% | 0.52% | +10.5% |
Q3 2019 | $8,496,000 | +1.2% | 215,027 | +5.2% | 0.47% | +12.5% |
Q2 2019 | $8,399,000 | -17.4% | 204,444 | -6.4% | 0.42% | -24.0% |
Q1 2019 | $10,174,000 | +0.2% | 218,464 | -6.3% | 0.55% | -24.1% |
Q4 2018 | $10,156,000 | -25.6% | 233,202 | -2.2% | 0.72% | -2.8% |
Q3 2018 | $13,642,000 | +23.6% | 238,379 | +4.8% | 0.74% | +11.3% |
Q2 2018 | $11,038,000 | +21.3% | 227,484 | -2.3% | 0.66% | +1.2% |
Q1 2018 | $9,100,000 | -5.2% | 232,746 | +2.9% | 0.66% | -13.0% |
Q4 2017 | $9,601,000 | +18.5% | 226,231 | +4.2% | 0.76% | +11.7% |
Q3 2017 | $8,102,000 | +41.5% | 217,091 | +15.2% | 0.68% | +28.0% |
Q2 2017 | $5,725,000 | +15.6% | 188,397 | +0.7% | 0.53% | +6.2% |
Q1 2017 | $4,952,000 | -71.5% | 187,092 | -72.5% | 0.50% | -16.6% |
Q4 2016 | $17,359,000 | -41.3% | 680,209 | -16.8% | 0.60% | -38.4% |
Q3 2016 | $29,573,000 | +14.6% | 817,149 | +7.6% | 0.97% | +2.9% |
Q2 2016 | $25,812,000 | +35.4% | 759,619 | +5.1% | 0.94% | +35.8% |
Q1 2016 | $19,066,000 | -40.4% | 722,469 | +10.1% | 0.69% | -37.1% |
Q4 2015 | $32,006,000 | +162.1% | 656,391 | +33.8% | 1.10% | +191.3% |
Q3 2015 | $12,212,000 | -17.7% | 490,436 | +4.6% | 0.38% | -10.0% |
Q2 2015 | $14,840,000 | -17.0% | 469,036 | -0.2% | 0.42% | -18.0% |
Q1 2015 | $17,880,000 | +50.0% | 469,776 | +53.5% | 0.51% | +47.1% |
Q4 2014 | $11,921,000 | – | 305,988 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |